Standout Papers

Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in... 2001 2026 2009 2017 898
  1. Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial (2001)
    Karen Kelly, John Crowley et al. Journal of Clinical Oncology

Immediate Impact

2 by Nobel laureates 7 from Science/Nature 72 standout
Sub-graph 1 of 20

Citing Papers

Cancer statistics, 2022
2022 Standout
Cancer Statistics, 2021
2021 Standout
1 intermediate paper

Works of Patra Grevstad being referenced

Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial
2001 Standout

Author Peers

Author Last Decade Papers Cites
Patra Grevstad 792 803 36 199 10 1.1k
George Armitage 553 987 36 207 14 1.4k
Jonathan J. Wilson 493 990 31 148 8 1.3k
E Rapp 896 899 59 263 12 1.3k
N.H. Gower 849 907 52 217 17 1.2k
Jeffrey Kirshner 590 733 88 125 10 1.3k
Joseph Ayoub 558 404 47 483 26 1.1k
NM Bleehen 405 455 59 261 22 1.1k
Santi Barbera 624 447 106 70 17 959
Francesco Rosetti 628 431 131 134 22 1.1k
М. Р. Личиницер 1038 249 22 168 14 1.2k

All Works

Loading papers...

Rankless by CCL
2026